Life at OSU

The National Institutes of Health has awarded a five-year grant of more than $1 million to Oregon State University’s Linus Pauling Institute and College of Pharmacy to support graduate students in the study of natural products with the potential to enhance human health.

A study of outpatient visits to health care providers in the United States during a one-year period suggests 18 percent of antibiotic prescriptions were written without a documented reason for doing so.

Oregon State University enrolled a record number of students, including increases in students of color and veterans, for fall term 2019. This growth has been fueled by increases in students attending the university’s nationally ranked online Ecampus program and OSU-Cascades in Bend.

A collaboration led by scientists at Oregon State University, the University of Oxford in the United Kingdom and Erasmus University in The Netherlands has identified a new genetic mutation behind the premature fusing of the bony plates that make up the skull.

Broader monitoring of patients is needed to reduce the number of people who develop a urinary tract infection after being discharged from the hospital, new research by Oregon State University suggests.

Researchers at Oregon State University and Oregon Health & Science University have found a possible counterpunch to the drug resistance of melanoma, the most dangerous form of skin cancer.

Antibiotics prescribed by dentists as a preemptive strike against infection are unnecessary 81% of the time, according to a study published today in JAMA Network Open.

A 2016 Oregon law allowing pharmacists to write birth control prescriptions is helping more women at risk for unintended pregnancies to use contraception, new research by Oregon State University suggests.

An Oregon State University researcher is part of a $1.94 million grant to look for possible connections between the human microbiome and autism spectrum disorder.

A pharmaceutical sciences researcher at Oregon State University has received a five-year, $3.3 million grant from the National Institutes of Health to develop a way for cystic fibrosis patients to get molecular treatment via an inhaler, a potential vast improvement over existing therapeutic methods.